Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease

Journal of Clinical Microbiology

Volumn 42, Issue 7, 2004, Pages 2980-2987

  Øvstebø, Reidun ^a   Brandtzaeg, Petter ^a   Brusletto, Berit ^a   Haug, Kari Bente Foss ^a   Lande, Knut ^a   Høiby, Ernst Arne ^b   Kierulf, Peter ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; LIPOPOLYSACCHARIDE;

ARTICLE; BACTERIAL COUNT; BACTERIAL GENE; BLOOD ANALYSIS; BLOOD CULTURE; BLOOD LEVEL; CAPSULAR TRANSPORT A GENE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA DETERMINATION; DNA ISOLATION; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ROBOTICS; ROBOTIZED DNA ISOLATION; SHOCK;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; NEISSERIA; NEISSERIA MENINGITIDIS;

EID: 3142783512     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.7.2980-2987.2004     Document Type: Article

References (35)

1. Andersen, B. M., O. Solberg, K. Bryn, L. O. Froholm, P. Gaustad, E. A. Hoiby, B. E. Kristiansen, and K. Bovre. 1987. Endotoxin liberation from Neisseria meningitidis isolated from carriers and clinical cases. Scand. J. Infect. Dis. 19:409-419.
2. Bjerre, A., B. Brusletto, T. E. Mollnes, E. Fritzsøonn, E. Rosenqvist, E. Wedege, E. Namork, P. Kierulf, and P. Brandtzaeg. 2002. Complement activation induced by purified Neisseria meningitidis lipopolysaccharides (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant. J. Infect. Dis. 185:220-228.
3. Bjerre, A., B. Brusletto, R. Ovstebo, G. B. Joo, P. Kierulf, and P. Brandtzaeg. 2003. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex. J. Endotoxin Res. 9:155-163.
4. Bjerre, A., B. Brusletto, E. Rosenqvist, E. Namork, P. Kierulf, R. Ovstebo, G. B. Joo, and P. Brandtzæg. 2000. Cellular activation properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide. J. Endotoxin Res. 6:437-445.
5. Brandtzaeg, P. 2003. Host response to Neisseria meningitidis lacking lipopolysaccharides. Expert Rev. Anti-infect. Ther. 1:89-96.
6. Brandtzaeg, P., A. Bjerre, R. Ovstebo, B. Brusletto, G. B. Joo, and P. Kierulf. 2001. Neisseria meningitidis lipopolysaccharides in human pathology. J. Endotoxin Res. 7:401-420.
7. Brandtzaeg, P., K. Bryn, P. Kierulf, R. Ovstebo, E. Namork, B. Aase, and E. Jantzen. 1992. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J. Clin. Investig. 89:816-823.
8. Brandtzaeg, P., P. Kierulf, P. Gaustad, A. Skulberg, J. N. Bruun, S. Halvorsen, and E. Sorensen. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159:195-204.
9. Brandtzaeg, P., R. Ovstebo, and P. Kierulf. 1992. Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J. Infect. Dis. 166:650-652.
10. Brandtzaeg, P., R. Ovstebo, and P. Kierulf. 2001. Quantitative detection of bacterial lipopolysaccharides in clinical specimens, p 427-439. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease, methods and protocols. The Humana Press, Totowa, N.J.
11. Caugant, D. A., E. A. Hoiby, L. O. Froholm, and P. Brandtzaeg. 1996. Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian meningococcal serogroup B protection trial. Scand. J. Infect. Dis. 28:149-153.
12. Corless, C. E., M. Guiver, R. Borrow, V. Edwards-Jones, A. J. Fox, and E. B. Kaczmarski. 2001. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J. Clin. Microbiol. 39:1553-1558.
13. De Voe, I. W., and J. E. Gilchrist. 1973. Release of endotoxin in the cell wall blebs during in vitro growth of Neisseria meningitidis. J. Exp. Med. 138:1156-1167.
14. Gedde-Dahl, T. W., E. A. Hoiby, A. Schillinger, A. Lystad, and K. Bovre. 1983. An epidemiological, clinical and microbiological follow-up study of incident meningococcal disease cases in Norway, winter 1981-1982. Material and epidemiology of the MenOPP project. NIPH Ann. 6:155-168.
15. Gray, S. J., R. Borrow, and E. B. Kaczmarski. 2001. Meningococcal serology, p. 61-87. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease, methods and protocols. The Humana Press, Totowa, N.J.
16. Guiver, M., and R. Borrow. 2001. PCR diagnosis, p. 23-39. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease, methods and protocols. The Humana Press, Totowa, N.J.
17. Guiver, M., R. Borrow, J. Marsh, S. J. Gray, E. B. Kaczmarski, D. Howells, P. Boseley, and A. J. Fox. 2000. Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol. Med. Microbiol. 28:173-179.
18. Hacket, S. J., M. Guiver, J. Marsh, J. A. Sills, A. P. Thomson, E. B. Kaczmarski, and C. A. Hart. 2002. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch. Dis. Child. 86:44-46.
19. Hoiby, E. A., G. Bjune, L. O. Froholm, J. Eng, A. Halstensen, E. Rosenqvist, E. Ronnild, and E. Wedege. 1991. The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis. NIPH Ann. 14:107-121.
20. Kristiansen, B. E., E. Ask, A. Jenkins, C. Fermer, P. Radstrom, and O. Skold. 1991. Rapid diagnosis of meningococcal meningitis by polymerase chain reaction. Lancet 337:1568-1569.
21. La Scolea, L. J., D. Dryja, D. Sullivan, L. Mosovich, N. Ellerstein, and F. Neter. 1981. Diagnosis of bacteremia in children by quantitative direct plating and a radiometric procedure. J. Clin. Microbiol. 13:478-482.
22. Lorenzen, D. R., F. Dux, U. Wolk, A. Tsirpouchtsidis, G. Haas, and T. F. Meyer. 1999. Immunoglobulin A1 protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines. J. Exp. Med. 190:1049-1058.
23. Meijerink, J., C. Mandigers, L. van de Locht, E. Tonnissen, F. Goodsaid, and J. Raemaekers. 2001. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative realtime PCR. J. Mol. Diagn. 3:55-61.
24. Namork, E., and P. Brandtzaeg. 2002. Fatal meningococcal septicaemia with "blebbing" meningococcus. Lancet 360:1741.
25. Olcén, P., and H. Fredlund. 2001. Isolation, culture, and identification of meningococci from clinical specimens, p 9-21. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease, methods and protocols. The Humana Press, Totowa, N.J.
26. Ovstebo, R., K. B. Haug, K. Lande, and P. Kierulf. 2003. PCR-based calibration curves for studies of quantitative gene expression in human monocytes: development and evaluation. Clin. Chem. 49:425-432.
27. Rosenqvist, E., E. A. Hoiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Ronnild, G. Bjune, and H. Nokleby. 1995. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:4642-4652.
28. Seward, R. J., and K. J. Towner. 2000. Evaluation of a PCR-immunoassay technique for detection of Neisseria meningitidis in cerebrospinal fluid and peripheral blood. J. Med. Microbiol. 49:451-456.
29. Sobanski, M. A., R. A. Barnes, and W. T. Coakley. 2001. Detection of meningococcal antigen by latex agglutination, p 41-59. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease, methods and protocols. The Humana Press, Totowa, N.J.
30. Sullivan, T. D., and L. J. LaScolea. 1987. Neisseria meningitidis bacteremia in children: quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy. Pediatrics 80:63-67.
31. Tettelin, H., N. J. Saunders, J. Heidelberg, A. C. Jeffries, K. E. Nelson, J. A. Eisen, K. A. Ketchum, D. W. Hood, J. F. Peden, R. J. Dodson, W. C. Nelson, M. L. Gwinn, R. DeBoy, J. D. Peterson, E. K. Hickey, D. H. Haft, S. L. Salzberg, O. White, R. D. Fleischmann, B. A. Dougherty, T. Mason, A. Ciecko, D. S. Parksey, E. Blair, H. Cittone, E. B. Clark, M. D. Cotton, T. R. Utterback, H. Khouri, H. Qin, J. Vamathevan, J. Gill, V. Scarlato, V. Masignani, M. Pizza, G. Grandi, L. Sun, H. O. Smith, C. M. Fraser, E. R. Moxon, R. Rappuoli, and J. C. Venter. 2000. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287:1809-1815.
32. Tzanakaki, G., M. Tsolia, V. Vlachou, M. Theodoridou, A. Pangalis, M. Foustoukou, T. Karpathios, C. C. Blackwell, and J. Kremastinou. 2003. Evaluation of non-culture diagnosis of invasive meningococcal disease by polymerase chain reaction (PCR). FEMS Immunol. Med. Microbiol. 39:31-36.
33. van Deuren, M., P. Brandtzaeg, and J. W. van der Meer. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13:144-166.
34. Wilson, I. G. 1997. Inhibition and facilitation of nucleic acid amplification. Appl. Environ. Microbiol. 63:3741-3751.
35. Zwahlen, A., and F. A. Waldvogel. 1984. Magnitude of bacteremia and complement activation during Neisseria meningitidis infection: study of two co-primary cases with different clinical presentations. Eur. J. Clin. Microbiol. 3:439-441.